“We’ll look back and say it was a good deal.” Takeda reveals early data for its $4 billion autoimmune disease pill. – The Boston Globe

Leave a Comment / Business / By
  1. “We’ll look back and say it was a good deal.” Takeda reveals early data for its $4 billion autoimmune disease pill.The Boston Globe
  2. Takeda’s $4 billion psoriasis pill helped clear skin in mid-term studyBloomberg
  3. Takeda Announces Positive Results in Phase 2b Study of Investigational TAK-279, a Once-Daily Oral TYK2 Inhibitor, in People With Moderate-to-Severe Plaque Psoriasisbusiness thread
  4. Takeda reveals early data for its $4 billion autoimmune disease pillSTAT
  5. Takeda rose to buy from BofA on growth prospects and debt repayment (NYSE:TAK)Looking for Alpha

Leave a Comment

Your email address will not be published. Required fields are marked *